ClinicalTrials.govpublic full text
Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density
hiv-1 infection, osteoporosis, bone mineral density, dual-energy x-ray absorptiometry, hiv infection, dolutegravir, integrase inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868627
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.